Results 201 to 210 of about 3,235 (226)

Tezepelumab in active osteoarthritis with asthma

Journal of Allergy and Clinical Immunology
Roberto Colli, Jakob Nilsson, Lukas Frischknecht   +2 more
openaire   +2 more sources

Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison

Journal of Medical Economics, 2022
Andrew Menzies-Gow, Pallavi Rane, Jennifer Rowell   +2 more
exaly  

Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study

Clinical and Experimental Allergy, 2023
Jonathan Corren, Jean-Pierre Llanos
exaly  

NAVIGATOR steers asthma patients to tezepelumab

Medicom Conference Report ATS 2022, 2022
Njira Lugogo, Rachel Giles
openaire   +1 more source

Tezepelumab in real-life practice: Characteristics of patients commenced and efficacy in a nationwide, Danish cohort of patients with severe asthma.

Journal of Allergy and Clinical Immunology: In Practice
Marianne Baastrup Soendergaard, K. E. J. Håkansson, Susanne Hansen, A. Bjerrum, J. Schmid, S. Johansson, L. Rasmussen, C. Johnsen, Barbara Bonnesen, Roxana Vijdea, A. von Bülow, Niels Steen Krogh, O. Hilberg, C. Ulrik, C. Porsbjerg   +14 more
semanticscholar   +1 more source

SEVERE EGPA – A ROLE FOR TEZEPELUMAB?

Annals of Allergy, Asthma & Immunology
R. Crawford, M. Sullivan, J. Azar, C. Costello, C. Freeman   +4 more
openaire   +1 more source

Tezepelumab bei schwerem, unkontrolliertem Asthma

Kompass Pneumologie, 2023
openaire   +1 more source

Dupilumab/Tezepelumab

Reactions Weekly
openaire   +1 more source

Tezepelumab COPD Exacerbation Study

Case Medical Research, 2019
openaire   +1 more source

A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men

Clinical Pharmacology in Drug Development, 2020
exaly